Medtronic (MDT) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Medtronic · Health Care · ref. ETF XLV · 51 calls · price $89.97
What the company does: Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.
📈 Medtronic (MDT) stock price
$89.97-2.2% over range
Aug 28, 25low $73.75 · high $105.35Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
76% recommend buying · 17 analysts
📊 JPI status : Medtronic is no longer in our current JPI rankings, but appeared in the past (2017) — its upside may be behind it. See the stocks picked in 2017 →
🎯 MDT price target & analyst consensus — price $89.97
The price target · all analysts combined (17 targets)
Highest target · 1 firm of 17$120+33.4%
Median target · of 17 targets$100+11.1%
Lowest target · 1 firm of 17$83-7.7%
Current price$89.97
Where these 17 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
1588%
$91 ↔ $120
Below
212%
$83 ↔ $85
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Bernstein — 67% of its targets hit on this sector (64 calls tested). It aims for $97 (+7.8 %), call made on June 6, 2026, maturing on June 6, 2027 (83 d ago).
The 10 reliable analysts
$100+11 %
The 7 other firms
$110+22 %
How to read it: the 10 reliable firms are not filtered by optimism — 8 aim above the price, 2 below, hence their $100 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 17 ratings (last 6 months)
Strong Buy00%
Buy1376%
Hold424%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 MDT price target all
All 16 calls, one by one, with our verdict on each firm.
→ See all 16 targets, analyst by analyst💡 The best analysts on MDT most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in MDT? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Medtronic? The JPI assistant answers using our backtest data.
💰 Medtronic dividend: yield, history & growth › open the full page
3.60%annual yield
📈 Steady dividend — 22 yrs of consecutive dividend increases
That's ~$2.85 per share per year.
📈 Medtronic fundamentals: valuation, margins & growth › open the full page
P/E 24.1Net margin 13.2 %Revenue growth +9.9 %Cheap for the growth
🔎 Detailed analyses
🏛️ Which US Congress members hold Medtronic (MDT)?
1 Congress member has disclosed MDT buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Daniel Goldman 1× · 25%
✅ Historical analyst reliability on MDT
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| CFRA | 100% | +18.3% | 2 |
| B of A Securities ↗ | 100% | +17.3% | 6 |
| JP Morgan ↗ | 100% | +16.0% | 7 |
| SunTrust Robinson Humphrey | 100% | +2.5% | 3 |
| BTIG ↗ | 86% | +15.7% | 7 |
| Evercore ISI Group ↗ | 80% | +4.3% | 5 |
| Barclays ↗ | 78% | +12.6% | 9 |
| Piper Sandler ↗ | 75% | +20.6% | 4 |
| Jefferies ↗ | 75% | +12.3% | 8 |
| BMO Capital ↗ | 71% | +14.9% | 7 |
See the other 17 firms
| RBC Capital ↗ | 25% | -5.3% | 8 |
| Truist Securities ↗ | 33% | -10.7% | 3 |
| Oppenheimer ↗ | 33% | -5.5% | 6 |
| Cowen & Co. | 33% | -4.4% | 3 |
| Goldman Sachs ↗ | 33% | +7.7% | 3 |
| Raymond James ↗ | 38% | -1.3% | 13 |
| Morgan Stanley ↗ | 43% | -5.7% | 7 |
| UBS ↗ | 45% | +5.7% | 11 |
| Wells Fargo ↗ | 50% | -6.0% | 12 |
| Stifel ↗ | 50% | -4.1% | 6 |
| Argus Research ↗ | 50% | -3.2% | 6 |
| Needham ↗ | 50% | -2.5% | 8 |
| Credit Suisse | 50% | +5.2% | 12 |
| Deutsche Bank ↗ | 55% | +8.2% | 11 |
| Mizuho ↗ | 57% | +4.3% | 7 |
| Bernstein ↗ | 67% | +6.4% | 3 |
| Citigroup ↗ | 68% | +9.0% | 25 |
📊 What $1,000 invested in Medtronic would be worth › open the full page
In short — $1,000 invested in Medtronic 10 years ago would be worth $1,030 today, i.e. +0%/yr on average. Best year: 2019 (+31%), worst: 2022 (-19%). Price performance, excluding dividends.
If I'd invested $1,000 in Medtronic
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $861 | -14% |
| 3 years ago | $935 | -7% |
| 5 years ago | $703 | -30% |
Return by year (Medtronic)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -24% | $760 (-24%) |
| 2025 | +13% | $861 (-14%) |
| 2024 | +4% | $894 (-11%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Medtronic
Loading news…
📋 All analyst calls on MDT
Filtered on — · ✕ show all
▲ Buy · 🎯$91
Price at call : $94.13 — upside -3%
Today : $89.97 — upside +1%
🎯 on MDT : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Aug 18, 27
matures : Aug 18, 27
▲ Buy · 🎯$100
Price at call : $87.54 — upside +14%
Today : $89.97 — upside +11%
🎯 on MDT : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
▲ Buy · 🎯$100
Price at call : $83.57 — upside +20%
Today : $89.97 — upside +11%
🎯 on MDT : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Jul 10, 27
matures : Jul 10, 27
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$105
Price at call : $83.83 — upside +25%
Today : $89.97 — upside +17%
🎯 on MDT : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
▲ Buy · 🎯$101
Price at call : $78.14 — upside +29%
Today : $89.97 — upside +12%
🎯 on MDT : no call matured yet · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Jun 17, 27
matures : Jun 17, 27
Goldman Sachs ↗
Jun 5, 26
■ Neutral neutral · not a buy · 🎯$83
Price at call : $80.69 — gap to target +3%
Today : $89.97 — gap to target -8%
🎯 on MDT : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Jun 5, 27
matures : Jun 5, 27
▲ Outperform · 🎯$97
Price at call : $80.69 — upside +20%
Today : $89.97 — upside +8%
🎯 on MDT : no call matured yet · 📊 on Health : 54.7% · +5.2% (64 calls)
in progress (365j)
matures : Jun 5, 27
matures : Jun 5, 27
■ Neutral neutral · not a buy · 🎯$85
Price at call : $81.67 — gap to target +4%
Today : $89.97 — gap to target -6%
🎯 on MDT : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
See the other 43 calls, newest to oldest
▲ Buy · 🎯$119
Price at call : $81.67 — upside +46%
Today : $89.97 — upside +32%
🎯 on MDT : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
RBC Capital ↗
Jun 4, 26
▲ Outperform · 🎯$118
Price at call : $81.93 — upside +44%
Today : $89.97 — upside +31%
🎯 on MDT : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
Wells Fargo ↗
Jun 4, 26
▲ Overweight · 🎯$102
Price at call : $81.93 — upside +24%
Today : $89.97 — upside +13%
🎯 on MDT : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
Leerink Partners ↗
Jun 4, 26
▲ Outperform · 🎯$104
Price at call : $81.93 — upside +27%
Today : $89.97 — upside +16%
🎯 on MDT : 0% (1 call matured) · 📊 on Health : 55.3% · -4.8% (38 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
■ Neutral neutral · not a buy · 🎯$85
Price at call : $81.93 — gap to target +4%
Today : $89.97 — gap to target -6%
🎯 on MDT : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
▲ Buy · 🎯$90
Price at call : $81.93 — upside +10%
Today : $89.97 — upside +0%
🎯 on MDT : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
▲ Outperform · 🎯$100
Price at call : $81.93 — upside +22%
Today : $89.97 — upside +11%
🎯 on MDT : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Jun 3, 27
matures : Jun 3, 27
▲ Buy · 🎯$101
Price at call : $81.93 — upside +23%
Today : $89.97 — upside +12%
🎯 on MDT : no call matured yet · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Jun 3, 27
matures : Jun 3, 27
■ Neutral neutral · not a buy · 🎯$90
Price at call : $83.79 — gap to target +7%
Today : $89.97 — gap to target +0%
🎯 on MDT : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Apr 22, 27
matures : Apr 22, 27
Truist Securities ↗
Apr 15, 26
■ Hold neutral · not a buy · 🎯$95
Price at call : $85.65 — gap to target +11%
Today : $89.97 — gap to target +6%
🎯 on MDT : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
▲ Outperform · 🎯$120
Price at call : $88.12 — upside +36%
Today : $89.97 — upside +33%
🎯 on MDT : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
Evercore ISI Group ↗
Apr 9, 26
▲ Outperform · 🎯$106
Price at call : $87.21 — upside +22%
Today : $89.97 — upside +18%
🎯 on MDT : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 9, 27
matures : Apr 9, 27
▲ Buy · 🎯$110
Price at call : $88.65 — upside +24%
Today : $89.97 — upside +22%
🎯 on MDT : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Apr 7, 27
matures : Apr 7, 27
Evercore ISI Group ↗
Apr 6, 26
▲ Outperform · 🎯$108
Price at call : $86.42 — upside +25%
Today : $89.97 — upside +20%
🎯 on MDT : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
Argus Research ↗
Apr 6, 26
▲ Buy · 🎯$115
Price at call : $86.42 — upside +33%
Today : $89.97 — upside +28%
🎯 on MDT : 0% (1 call matured) · 📊 on Health : 55.7% · +2.6% (158 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
▲ Overweight · 🎯$120
Price at call : $86.63 — upside +39%
Today : $89.97 — upside +33%
🎯 on MDT : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Apr 1, 27
matures : Apr 1, 27
Piper Sandler ↗
Apr 1, 26
■ Neutral neutral · not a buy · 🎯$91
Price at call : $86.63 — gap to target +5%
Today : $89.97 — gap to target +1%
🎯 on MDT : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Apr 1, 27
matures : Apr 1, 27
▲ Buy · 🎯$120
Price at call : $87.67 — upside +37%
Today : $89.97 — upside +33%
🎯 on MDT : no call matured yet · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Mar 26, 27
matures : Mar 26, 27
▲ Buy · 🎯$120
Price at call : $88.97 — upside +35%
Today : $89.97 — upside +33%
🎯 on MDT : no call matured yet · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Mar 10, 27
matures : Mar 10, 27
■ Neutral neutral · not a buy · 🎯$100
Price at call : $97.58 — gap to target +2%
Today : $89.97 — gap to target +11%
🎯 on MDT : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Feb 18, 27
matures : Feb 18, 27
▲ Overweight · 🎯$118
Price at call : $97.58 — upside +21%
Today : $89.97 — upside +31%
🎯 on MDT : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Feb 18, 27
matures : Feb 18, 27
■ Neutral neutral · not a buy · 🎯$100
Price at call : $98.49 — gap to target +2%
Today : $89.97 — gap to target +11%
🎯 on MDT : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Feb 18, 27
matures : Feb 18, 27
▲ Buy · 🎯$120
Price at call : $96.41 — upside +24%
Today : $89.97 — upside +33%
🎯 on MDT : no call matured yet · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Feb 17, 27
matures : Feb 17, 27
▲ Buy · 🎯$121
Price at call : $101.65 — upside +19%
Today : $89.97 — upside +34%
🎯 on MDT : no call matured yet · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Feb 9, 27
matures : Feb 9, 27
■ Neutral neutral · not a buy · 🎯$104
Price at call : $102.95 — gap to target +1%
Today : $89.97 — gap to target +16%
🎯 on MDT : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Feb 4, 27
matures : Feb 4, 27
▲ Outperform · 🎯$112
Price at call : $96.95 — upside +16%
Today : $89.97 — upside +24%
🎯 on MDT : no call matured yet · 📊 on Health : 54.7% · +5.2% (64 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
▲ Overweight · 🎯$116
Price at call : $97.53 — upside +19%
Today : $89.97 — upside +29%
🎯 on MDT : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
William Blair ↗
Jan 6, 26
▲ Outperform
🎯 on MDT : no call matured yet · 📊 on Health : 63% · +5.2% (27 calls)
in progress (365j)
matures : Jan 6, 27
matures : Jan 6, 27
Truist Securities ↗
Dec 18, 25
■ Hold neutral · not a buy · 🎯$107
Price at call : $98.63 — gap to target +8%
Today : $89.97 — gap to target +19%
🎯 on MDT : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Dec 18, 26
matures : Dec 18, 26
▲ Overweight · 🎯$111
Price at call : $101.2 — upside +10%
Today : $89.97 — upside +23%
🎯 on MDT : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Nov 20, 26
matures : Nov 20, 26
Truist Securities ↗
Nov 20, 25
■ Hold neutral · not a buy · 🎯$110
Price at call : $101.2 — gap to target +9%
Today : $89.97 — gap to target +22%
🎯 on MDT : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Nov 20, 26
matures : Nov 20, 26
Morgan Stanley ↗
Nov 19, 25
▲ Overweight · 🎯$117
Price at call : $99.35 — upside +18%
Today : $89.97 — upside +30%
🎯 on MDT : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Nov 19, 26
matures : Nov 19, 26
RBC Capital ↗
Nov 19, 25
▲ Outperform · 🎯$118
Price at call : $99.35 — upside +19%
Today : $89.97 — upside +31%
🎯 on MDT : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Nov 19, 26
matures : Nov 19, 26
■ Neutral neutral · not a buy · 🎯$102
Price at call : $99.35 — gap to target +3%
Today : $89.97 — gap to target +13%
🎯 on MDT : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Nov 19, 26
matures : Nov 19, 26
Wells Fargo ↗
Nov 19, 25
▲ Overweight · 🎯$114
Price at call : $100.34 — upside +14%
Today : $89.97 — upside +27%
🎯 on MDT : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Nov 19, 26
matures : Nov 19, 26
■ Neutral neutral · not a buy · 🎯$109
Price at call : $100.34 — gap to target +9%
Today : $89.97 — gap to target +21%
🎯 on MDT : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Nov 19, 26
matures : Nov 19, 26
Goldman Sachs ↗
Nov 19, 25
■ Neutral neutral · not a buy · 🎯$111
Price at call : $100.34 — gap to target +11%
Today : $89.97 — gap to target +23%
🎯 on MDT : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Nov 19, 26
matures : Nov 19, 26
■ Neutral neutral · not a buy · 🎯$100
Price at call : $95.87 — gap to target +4%
Today : $89.97 — gap to target +11%
🎯 on MDT : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Nov 13, 26
matures : Nov 13, 26
Truist Securities ↗
Oct 15, 25
■ Hold neutral · not a buy · 🎯$103
Price at call : $95.04 — gap to target +8%
Today : $89.97 — gap to target +14%
🎯 on MDT : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Oct 15, 26
matures : Oct 15, 26
■ Hold neutral · not a buy · 🎯$105
Price at call : $95.45 — gap to target +10%
Today : $89.97 — gap to target +17%
🎯 on MDT : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Oct 9, 26
matures : Oct 9, 26
▲ Buy · 🎯$112
Price at call : $97.87 — upside +14%
Today : $89.97 — upside +24%
🎯 on MDT : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Oct 7, 26
matures : Oct 7, 26
Argus Research ↗
Aug 26, 25
▲ Buy · 🎯$115
Price at call : $92.05 — upside +25%
Today : $89.97 — upside +28%
Expected +25% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on MDT : 0% (1 call matured) · 📊 on Health : 55.7% · +2.6% (158 calls)
-2.3%
stock -2% · XLV +25%
matured Aug 26, 26
Leerink Partners ↗
Jun 16, 25
▲ Outperform · 🎯$110
Price at call : $87.92 — upside +25%
Today : $89.97 — upside +22%
Expected +25% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on MDT : 0% (1 call matured) · 📊 on Health : 55.3% · -4.8% (38 calls)
-7.5%
stock -8% · XLV +13%
matured Jun 16, 26
Frequently asked questions
Should I buy Medtronic stock?
This isn't buy advice. For Medtronic, the analyst consensus is "Buy", with an average price target of $100 (+11% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Medtronic). We show the numbers — you decide.
Is it too late to buy Medtronic? How high can it go?
The most bullish analyst target on Medtronic is $120 (+33% above today's price); the average is $100. That's the upside they see. Check how reliable those analysts have actually been on Medtronic on our site before trusting it.
Is Medtronic still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 27 analysts have a real record on Medtronic, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Medtronic? The case for and against
The arguments for and against, one by one, from the numbers: why invest in MDT (and why hesitate).
What has Medtronic's past performance been?
Historical returns and a "how much if I had invested" calculator: MDT performance & returns.
Does Medtronic pay a dividend?
Yield, consistency and growth history of the dividend: MDT's dividend.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX